Date:2/9/2009

sets 71.5 113.0 ---- ----- Total assets $3,572.8 $3,594.3 ======== ======== Liabilities and Stockholders' Equity Current liabilities Accounts payable $172.2 $224.8 Accrued expenses 416.9 438.2 Income taxes payable 29.7 32.0 Short-term borrowings 21.4 89.4 Current maturities of long-term debt 4.4 12.8 --- ---- Total current liabilities 644.6 797.2 Long-term debt, less current maturities 896.3 888.6 Deferred income taxes - 73.4 Other liabilities 595.9 393.4 ----- ----- Total liabilities 2,136.8 2,152.6 ------- ------- Commitments and contingencies Stockholders' equity Preferred stock - - Common stock 6.9 6.8 Additional paid-in capital 559.2 519.3 Retained earnings 1,397.6 1,246.2 Accumulated other comprehensive loss (199.8) (12.8) Treasury stock, at cost (327.9) (317.8) Common stock held in grantor trust, at cost (19.3) (17.8) Grantor trust liability 19.3 17.8
'/>"/>

SOURCE Beckman Coulter - IR Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33
Related biology technology :

1. Beckman Coulter to Present at the Bear Stearns Healthcare Conference
2. Beckman Coulter to Present at the UBS Global Life Sciences Conference
3. Beckman Coulter Announces Third Quarter 2007 Earnings to Be Released on Tuesday, October 30, 2007 Before Market Opens
4. Beckman Coulter Declares Quarterly Dividend
5. Beckman Coulter Announces Third Quarter 2007 Results
6. Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference
7. Beckman Coulter to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
8. Beckman Coulter to Acquire Exclusive Rights to Break-Through Technologies
9. Beckman Coulter Elects AMN Healthcare Executive to Board of Directors
10. Beckman Coulter to Present at the JPMorgan Healthcare Conference
11. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards